Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Salvo

Showing results (11-20 of 193) with videos related to

Pageof 20
Sort By:
The Journal of Clinical Endocrinology and Metabolism|June 16, 2025
Letter to the Editor from Raschi et al.: "Endocrine adverse reactions of tyrosine kinase inhibitors in combination with immune checkpoint inhibitors"Emanuel Raschi, Monia Donati, Francesco Salvo, et al.
Frontiers in Pharmacology|December 12, 2024
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guidelineMichele Fusaroli, Francesco Salvo, Charles Khouri, et al.
BMJ (Clinical Research Ed.)|November 3, 2022
Transparency and robustness of safety signalsCharles Khouri, Michele Fusaroli, Francesco Salvo, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBaseFabrizio Calapai, Carmen Mannucci, Liana McQuain, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)Alemayehu Lelisa Duga, Francesco Salvo, Alexander Kay, et al.
Drug Safety|November 5, 2023
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in FranceSibylle de Germay, Allison Singier, Francesco Salvo, et al.
Alcoholism, Clinical and Experimental Research|July 27, 2007
Intake of energy drinks in association with alcoholic beverages in a cohort of students of the School of Medicine of the University of MessinaAlessandro Oteri, Francesco Salvo, Achille Patrizio Caputi, et al.
Lancet (London, England)|March 22, 2016
Does paracetamol still have a future in osteoarthritis?Nicholas Moore, Francesco Salvo, Mai Duong, et al.
Drug Safety|May 8, 2024
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance CentersAntoine Pariente, Francesco Salvo, Virginie Bres, et al.
Journal of the American College of Cardiology|May 7, 2016
Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting SystemsEmanuel Raschi, Francesco Salvo, Elisabetta Poluzzi, et al.
Pageof 20

Showing results (11-20 of 193) with videos related to

Sort By:
Pageof 20
The Journal of Clinical Endocrinology and Metabolism|June 16, 2025
Letter to the Editor from Raschi et al.: "Endocrine adverse reactions of tyrosine kinase inhibitors in combination with immune checkpoint inhibitors"Emanuel Raschi, Monia Donati, Francesco Salvo, et al.
Frontiers in Pharmacology|December 12, 2024
The reporting of disproportionality analysis in pharmacovigilance: spotlight on the READUS-PV guidelineMichele Fusaroli, Francesco Salvo, Charles Khouri, et al.
BMJ (Clinical Research Ed.)|November 3, 2022
Transparency and robustness of safety signalsCharles Khouri, Michele Fusaroli, Francesco Salvo, et al.
Pharmaceuticals (Basel, Switzerland)|October 28, 2023
Pharmacological Evaluation of Signals of Disproportionality Reporting Related to Adverse Reactions to Antiepileptic Cannabidiol in VigiBaseFabrizio Calapai, Carmen Mannucci, Liana McQuain, et al.
Antibiotics (Basel, Switzerland)|May 27, 2023
Safety Profile of Medicines Used for the Treatment of Drug-Resistant Tuberculosis: A Descriptive Study Based on the WHO Database (VigiBase<sup>®</sup>)Alemayehu Lelisa Duga, Francesco Salvo, Alexander Kay, et al.
Drug Safety|November 5, 2023
Impact of Covid-19 Vaccination on Spontaneous Pharmacovigilance Reporting in FranceSibylle de Germay, Allison Singier, Francesco Salvo, et al.
Alcoholism, Clinical and Experimental Research|July 27, 2007
Intake of energy drinks in association with alcoholic beverages in a cohort of students of the School of Medicine of the University of MessinaAlessandro Oteri, Francesco Salvo, Achille Patrizio Caputi, et al.
Lancet (London, England)|March 22, 2016
Does paracetamol still have a future in osteoarthritis?Nicholas Moore, Francesco Salvo, Mai Duong, et al.
Drug Safety|May 8, 2024
Can We Ask ChatGPT About Drug Safety? Appropriateness of ChatGPT Responses to Questions About Drug Use and Adverse Reactions Received by Pharmacovigilance CentersAntoine Pariente, Francesco Salvo, Virginie Bres, et al.
Journal of the American College of Cardiology|May 7, 2016
Safety Meta-Analysis: A Call for Appropriate Use of Disproportionality Measures From Spontaneous Reporting SystemsEmanuel Raschi, Francesco Salvo, Elisabetta Poluzzi, et al.
Pageof 20